Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Kbtbd13</i> knockdown restores muscle function in a clinically relevant mouse model of nemaline myopathy type 6.

Science translational medicine·2026

Same author

Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.

Human molecular genetics·2026

Same author

The contribution of mechanical ventilation to critical illness-associated diaphragm dysfunction: a critical appraisal.

Critical care (London, England)·2026

Same author

Species-specific effects of positive end-expiratory pressure on diaphragm and chest wall geometry in mice, rats, and humans.

American journal of physiology. Regulatory, integrative and comparative physiology·2026

Same author

Loss of Myonuclei and Transcriptional Activity During Diaphragm Atrophy in Critically Ill Patients.

Journal of cachexia, sarcopenia and muscle·2026

Same author

Physiological Effects of High-Flow Nasal Oxygen Compared With Conventional Oxygen Therapy: A Randomized Trial in Postextubation Patients.

Critical care medicine·2025

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound

Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound

Published on: November 3, 2023

Diaphragm adaptations in patients with COPD.

Coen A C Ottenheijm¹, Leo M A Heunks, Richard P N Dekhuijzen

¹Dept. of Molecular and Cellular Biology, University of Arizona, Tucson, USA. coeno@email.arizona.edu

Respiratory Research

|January 26, 2008

Summary

Inspiratory muscle weakness in chronic obstructive pulmonary disease (COPD) stems from cellular damage and protein loss, not just hyperinflation. Targeting the ubiquitin-proteasome pathway may reduce diaphragm wasting in COPD patients.

More Related Videos

Diaphragmatic Ultrasound in Adults: Image Acquisition and Interpretation

Diaphragmatic Ultrasound in Adults: Image Acquisition and Interpretation

Published on: January 31, 2025

Related Experiment Videos

Last Updated: Jul 8, 2026

Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound

Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound

Published on: November 3, 2023

Diaphragmatic Ultrasound in Adults: Image Acquisition and Interpretation

Diaphragmatic Ultrasound in Adults: Image Acquisition and Interpretation

Published on: January 31, 2025

Area of Science:

Pulmonary Medicine
Respiratory Physiology
Cellular Biology

Background:

Inspiratory muscle weakness is clinically significant in COPD, impacting survival.
Traditionally attributed to hyperinflation, new evidence points to cellular pathology.
Diaphragm dysfunction is a key concern in COPD management.

Purpose of the Study:

To review the cellular and molecular mechanisms underlying diaphragm weakness in COPD.
To explore the role of oxidative stress, sarcomeric injury, and proteolytic pathways.
To identify potential therapeutic targets for diaphragm wasting in COPD.

Main Methods:

Review of invasive diaphragm evaluations (contractile function, structure, biochemistry).
Analysis of cellular and molecular alterations in COPD diaphragms.
Examination of early-stage disease (GOLD I/II) pathology.

Main Results:

COPD diaphragms exhibit pathological cellular alterations, including reduced force generation and myosin loss.
Oxidative stress and sarcomeric injury are implicated in activating proteolytic machinery.
These changes lead to contractile protein wasting and reduced diaphragm fiber force.
Pathological alterations are present even in early stages of COPD.

Conclusions:

Diaphragm weakness in COPD involves cellular pathology beyond hyperinflation, including protein wasting.
Oxidative stress and sarcomeric injury activate proteolytic pathways contributing to muscle wasting.
The ubiquitin-proteasome pathway is a promising therapeutic target for diaphragm dysfunction in COPD.